Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-24 @ 5:28 PM
NCT ID:
NCT07023068
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years, regardless of gender.
* Patients clinically confirmed or suspected of lung cancer, with pathological specimens obtainable via biopsy or surgery within the recent 2 months.
* At least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.
* Expected survival \>3 months.
Exclusion Criteria:
* Severe hepatic or renal dysfunction (serum creatinine \>3.0 mg/dL or any liver enzyme level ≥5× upper limit of normal).
* Women who are planning pregnancy, pregnant, or breastfeeding.
* Inability to lie supine for 30 minutes.
* Claustrophobia or other psychiatric disorders.
* Intolerance to any clinical procedures in the study.
* Other conditions deemed ineligible by the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT07023068
Study Brief:
Protocol Section:
NCT07023068